Medipost Co (XKRX:078160) ROCE % : 14.51% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medipost Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.51%.

Medipost Co ROCE % Historical Data

The historical data trend for Medipost Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co ROCE % Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-2.58

4.27

2.25

6.49

3.43

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															13.87	-5.77	11.22	-7.31	14.51

Medipost Co ROCE % Calculation

Medipost Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	10803.118	/	( ( (397790.903 - 154588.012)	+	(449392.586 - 63321.097) )	/ 2 )
	=	10803.118	/	( (243202.891	+	386071.489)	/ 2 )
	=	10803.118	/	314637.19
	=	3.43 %

Medipost Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	49869.96	/	( ( (391091.968 - 89755.071)	+	(449392.586 - 63321.097) )	/ 2 )
	=	49869.96	/	( ( 301336.897	+	386071.489 )	/ 2 )
	=	49869.96	/	343704.193
	=	14.51 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Medipost Co (XKRX:078160) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medipost Co ROCE % Related Terms

Thank you for viewing the detailed overview of Medipost Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines